The market for palliative care in hematologic malignancies is witnessing significant growth as the incidence of these types of cancers continues to rise. The market is driven by the increasing recognition of the unique challenges and symptom burden associated with hematologic malignancies, such as leukemia, lymphoma, and multiple myeloma. Palliative care services aimed at managing pain, fatigue, and other symptoms, as well as addressing psychosocial and spiritual needs, are in high demand. The integration of palliative care into the treatment plans for hematologic malignancies is gaining prominence. However, challenges like limited awareness among healthcare providers, variations in access to palliative care services, and the need for specialized expertise persist. The market for palliative care in hematologic malignancies is expected to continue growing as healthcare systems focus on improving the quality of life and supportive care for patients with these conditions.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
